Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women
Morbid Obesity, Cesarean Delivery Affecting Fetus
About this trial
This is an interventional prevention trial for Morbid Obesity focused on measuring Fetal pH, CPAP, Continuous Positive Airway Pressure
Eligibility Criteria
Inclusion Criteria:
- Pregnant women between the ages of 18-45
- Body mass index of 40 kg/m2 or greater at the time patient is scheduled for cesarean delivery
- Singleton gestation
- Scheduled for primary or repeat cesarean delivery at Sentara Norfolk General Hospital
- Gestational age between 37+0 and 41+0 weeks at the time of delivery
- Non-stress test on admission with moderate variability, without repetitive late or variable decelerations
- Negative SARS-CoV-2 PCR test within 72 hours of procedure
Exclusion Criteria:
- Fetal growth restriction
- Active pulmonary diseases to include pneumonia, sarcoidosis, pulmonary hypertension, moderate or severe persistent asthma
- Suspected placenta accreta based on prenatal sonographic evaluation
- Active maternal infection to include pyelonephritis, appendicitis, upper respiratory tract infection, urinary tract infection or suspected intra-amniotic infection
- SARS-CoV-2 positive test within past 10 days or ongoing symptoms of SARS-CoV-2 to include cough, fever or shortness of breath with positive test greater than 10 days prior, or history of hospitalization for SARS-CoV-2 infection
- Fetus with aneuploidy or major anomaly
- Enrolled in another trial that may affect outcome
Sites / Locations
- Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical SchoolRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Continuous Positive Airway Pressure
Nasal Cannula
Those randomized to CPAP will be fitted with CPAP face mask or nasal device by the respiratory therapist and permitted to trial the machine to ensure proper use and fit. CPAP settings: CPAP AUTO 5-20 cm H20 will be utilized. The CPAP device will then be removed. The subject will then be placed in the supine position with a standard roll placed under the right maternal hip. Those randomized to CPAP will have the device applied and machine turned on. For those randomized to routine airway management, nasal cannula with oxygen 2L/min will be applied and this will be titrated to achieve a maternal SpO2 > 95%. End tidal CO2 monitors will be applied to both patient groups.
For those randomized to routine airway management, nasal cannula with oxygen 2L/min will be applied and this will be titrated to achieve a maternal SpO2 > 95%. End tidal CO2 monitors will be applied to both patient groups.